Defining the Phenotypes of Sickle Cell Disease

The sickle cell gene is pleiotropic in nature. Although it is a single gene mutation, it has multiple phenotypic expressions that constitute the complications of sickle cell disease. The frequency and severity of these complications vary considerably both latitudinally in patients and longitudinally in the same patient over time. Thus, complications that occur in childhood may disappear, persist or get worse with age. Dactylitis and stroke, for example, occur mostly in childhood, whereas leg ulcers and renal failure typically occur in adults. It is essential that the phenotypic manifestations of sickle cell disease be defined accurately so that communication among providers and researchers facilitates the implementation of appropriate and cost-effective diagnostic and therapeutic modalities. The aim of this review is to define the complications that are specific to sickle cell disease based on available evidence in the literature and the experience of hematologists in this field.

[1]  D. Weatherall,et al.  Hepatic sequestration in sickle cell anaemia. , 1985, British medical journal.

[2]  T. S. St. Pierre,et al.  Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.

[3]  J. Stockman Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia , 2012 .

[4]  Z. Rogers Priapism in sickle cell disease. , 2005, Hematology/oncology clinics of North America.

[5]  J. Krishnan,et al.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.

[6]  S. Aractingi,et al.  Sickle cell leg ulcers: a frequently disabling complication and a marker of severity , 2007, The British journal of dermatology.

[7]  M. Dana,et al.  Spontaneous and traumatic vitreous hemorrhage. , 1993, Ophthalmology.

[8]  A. S. Appel,et al.  ACUTE RENAL FAILURE , 1967, Advances in Experimental Medicine and Biology.

[9]  R. Bellomo,et al.  Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.

[10]  Cage S. Johnson Arterial blood pressure and hyperviscosity in sickle cell disease. , 2005, Hematology/oncology clinics of North America.

[11]  L. Benjamin,et al.  Definitions of the phenotypic manifestations of sickle cell disease , 2009, American journal of hematology.

[12]  S. Ballas,et al.  Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia , 2006, Transfusion.

[13]  I. Roberts,et al.  Bone involvement in sickle cell disease , 2005, British journal of haematology.

[14]  A. Wolffe,et al.  DNA methylation in health and disease , 2000, Nature Reviews Genetics.

[15]  M. Goldberg Classification and pathogenesis of proliferative sickle retinopathy. , 1971, American journal of ophthalmology.

[16]  P. V. Ichinsky,et al.  Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease , 2000 .

[17]  Charles Owen,et al.  Sickle cell hepatopathy , 2001, Hepatology.

[18]  D. Powars,et al.  Sickle cell anemia. Beta s gene cluster haplotypes as genetic markers for severe disease expression. , 1993, American journal of diseases of children.

[19]  J. Mohr,et al.  Transient ischemic attack--proposal for a new definition. , 2002, The New England journal of medicine.

[20]  E. Vichinsky,et al.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. , 2000, The New England journal of medicine.

[21]  R. Powell,et al.  Acute splenic sequestration crisis in sickle cell disease: early detection and treatment. , 1992, Journal of pediatric surgery.

[22]  M. Weiner,et al.  Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. , 2010, JAMA.

[23]  M. Kerstein,et al.  Leg ulcers in patients with sickle cell disease. , 1996, Advances in wound care : the journal for prevention and healing.

[24]  J. Curé,et al.  Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. , 2002, Blood.

[25]  E. Orringer,et al.  Sickle cell intrahepatic cholestasis: approach to a difficult problem. , 1995, The American journal of gastroenterology.

[26]  J. Smith,et al.  Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. , 1992, Journal of clinical epidemiology.

[27]  D. Powars Sickle cell anemia and major organ failure. , 1990, Hemoglobin.

[28]  M. DeBaun,et al.  Finally, a consensus statement on sickle cell disease manifestations: A critical step in improving the medical care and research agenda for individuals with sickle cell disease , 2009, American journal of hematology.

[29]  K. Blethyn,et al.  Pain management in sickle cell disease , 2006, Chronic illness.

[30]  R. Nagel,et al.  Structure and Properties of Hemoglobin Charlem, a Human Hemoglobin Variant with Amino Acid Substitutions in 2 Residues of the β-Polypeptide Chain , 1967 .

[31]  M. Espeland,et al.  Developmental pattern of splenic dysfunction in sickle cell disorders. , 1985, Pediatrics.

[32]  S. Baker,et al.  Liver biopsy results in patients with sickle cell disease on chronic transfusions: Poor correlation with ferritin levels , 2008, Pediatric blood & cancer.

[33]  P. Levy,et al.  Leg ulcers in patients with sickle cell disease. , 1989, Blood.

[34]  Scott T. Miller,et al.  Cerebrovascular accidents in sickle cell disease: rates and risk factors. , 1998, Blood.

[35]  R. McKinstry,et al.  Etiology of strokes in children with sickle cell anemia. , 2006, Mental retardation and developmental disabilities research reviews.

[36]  S. Ballas Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. , 2001, Seminars in hematology.

[37]  O. Castro,et al.  Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. , 1997, Blood.

[38]  S. Ballas Neurocognitive complications of sickle cell anemia in adults. , 2010, JAMA.

[39]  R. Ware,et al.  Subclinical Parvovirus B19 Infection in Children With Sickle Cell Anemia , 2003, Journal of pediatric hematology/oncology.

[40]  George C. Williams,et al.  PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.